Disruption of a single copy of the p38α MAP kinase gene leads to cardioprotection against ischemia-reperfusion

被引:60
作者
Otsu, K
Yamashita, N
Nishida, K
Hirotani, S
Yamaguchi, O
Watanabe, T
Hikoso, S
Higuchi, Y
Matsumura, Y
Maruyama, M
Sudo, T
Osada, H
Hori, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Med Informat Sci, Suita, Osaka 5650871, Japan
[3] RIKEN, Antibiot Lab & Bioarchitect Grp, Wako, Saitama 3510198, Japan
关键词
ischemia-reperfusion; p38 mitogen-activated protein kinase; heart; cardioprotection; necrosis;
D O I
10.1016/S0006-291X(03)00096-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p38 mitogen-activated protein kinase (p38) is activated in the heart during ischemia-reperfusion. However, it is not clear whether the activation of p38 is the protective response or the kinase mediates the cellular damage by ischemia-reperfusion. We examined the role of p38alpha in ischemia-reperfusion injury by studying p38alpha(+/-) mice. The p38alpha protein level in the p38alpha(+/-) heart was 50+/-8.7% compared with that in the p38alpha(+/+) heart. Upon reperfusion following ischemia for 25 min, p38alpha activity was transiently increased. The maximum level of p38 activity in p38alpha(+/-) was 60+/-10.5% compared with that in p38alpha(+/+). In the p38alpha(+/+) heart, 25 min ischemia and 2 h reperfusion resulted in necrotic injury (37.1+/-2.7% of the area at risk), whereas infarct size was drastically reduced to 7.2+/-0.7% in the P38alpha(+/-) heart. These suggested that p38alpha plays a pivotal role in the signal transduction pathway mediating myocardial cell death caused by ischemia-reperfusion. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 27 条
[1]   Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development [J].
Adams, RH ;
Porras, A ;
Alonso, G ;
Jones, M ;
Vintersten, K ;
Panelli, S ;
Valladares, A ;
Perez, L ;
Klein, R ;
Nebreda, AR .
MOLECULAR CELL, 2000, 6 (01) :109-116
[2]   Deficiency of the stress kinase p38α results in embryonic lethality:: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells [J].
Allen, M ;
Svensson, L ;
Roach, M ;
Hambor, J ;
McNeish, J ;
Gabel, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :859-869
[3]   MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure [J].
Arber, S ;
Hunter, JJ ;
Ross, J ;
Hongo, M ;
Sansig, G ;
Borg, J ;
Perriard, JC ;
Chien, KR ;
Caroni, P .
CELL, 1997, 88 (03) :393-403
[4]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[5]   Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059 -: SB 203580 also inhibits thromboxane synthase [J].
Börsch-Haubold, AG ;
Pasquet, S ;
Watson, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28766-28772
[6]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[7]   Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion [J].
Ma, XL ;
Kumar, S ;
Gao, F ;
Louden, CS ;
Lopez, BL ;
Christopher, TA ;
Wang, CL ;
Lee, JC ;
Feuerstein, GZ ;
Yue, TL .
CIRCULATION, 1999, 99 (13) :1685-1691
[8]   An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia [J].
Mackay, K ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6272-6279
[9]   Antiischemic effects of SB203580 are mediated through the inhibition of p38α mitogen-activated protein kinase -: Evidence from ectopic expression of an inhibition-resistant kinase [J].
Martin, JL ;
Avkiran, M ;
Quinlan, RA ;
Cohen, P ;
Marber, MS .
CIRCULATION RESEARCH, 2001, 89 (09) :750-752
[10]   Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2 [J].
Maulik, N ;
Yoshida, T ;
Zu, YL ;
Sato, M ;
Banerjee, A ;
Das, DK .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05) :H1857-H1864